[%%IMAGE1%%]<p>  Samsung Bioepis has launched a biosimilar (a medical product that is nearly identical to another) of Humira, the world’s best-selling prescription drug, called Imraldi. The company announced on Oct. 17 that Imraldi has hit markets in Europe. Originally developed by the US pharmaceutical firm AbbVie and released in 2002, Humira is used to treat autoimmunity diseases such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's disease. Global sales from Humira in 2017 totaled around US$17.6 billion. Professors Frances Arnold of the California Institute of Technology, George Smith from the University of Missouri and Gregory Winter of Britain’s MRC Laboratory of Molecular Biology were awarded the 2018 Nobel Prize for Chemistry for their work, which led to the drug’s development. (provided by Samsung Bioepis)</p>

english_edition

e_business

[Photo] Samsung Bioepis launches biosimilar of world’s best-selling drug

We are not impotent, but, quite on the contrary, omnipotent, without being able to determine the scope of our powers

[Column] Life on our Trisolaris

Six times thus far state commissions have slapped broadcasters with penalties for making reference to stock price manipulation allegations faced by Kim Keon-hee

[Editorial] Penalties for airing allegations against Korea’s first lady endanger free press

Spending millions on SM-3 interceptor missiles will not protect South Korea

[Editorial] Yoon must halt procurement of SM-3 interceptor missiles

Questions remain as to whether a population decline necessarily dictates a pessimistic future for a country

[Guest essay] Maybe Korea’s rapid population decline is an opportunity, not a crisis

Humbled in his domestic policy by an election defeat, Yoon should use this opportunity to reflect on his administration’s diplomacy as well

[Column] Can Yoon steer diplomacy with Russia, China back on track?

An independent probe into the death of a Marine could expose manipulation of state affairs

[Column] Season 2 of special prosecutor probe may be coming to Korea soon

Park Geun-hye’s experience is a cautionary tale for Yoon

[Column] Park Geun-hye déjà vu in Yoon Suk-yeol

The extreme confrontation unfolding now between South and North is one where even a small mistake could lead to disaster

[Editorial] New weight of N. Korea’s nuclear threats makes dialogue all the more urgent

Even Rhee himself insisted that the government established in 1948 was “reconstructing” the government established in 1919 by independence activists

[Guest essay] The real reason Korea’s new right wants to dub Rhee a founding father

Mutual acknowledgment is the first step to peace and coexistence, so perhaps we in South Korea should give up the term “Bukhan” (North Korea) for the name it prefers: “Choson”

[Column] ‘Choson’: Is it time we start referring to N. Korea in its own terms?

New sex-ed guidelines forbid teaching about homosexuality

OECD upgrades Korea’s growth forecast from 2.2% to 2.6%

60% of young Koreans see no need to have kids after marriage

Inside the law for a special counsel probe over a Korean Marine’s death

Korean government’s compromise plan for medical reform swiftly rejected by doctors

Months and months of overdue wages are pushing migrant workers in Korea into debt

Two lung cancer deaths at Samsung Electronics deemed occupational in nature

Trump asks why US would defend Korea, hints at hiking Seoul’s defense cost burden

전체

윤 대통령, 청와대로 어린이 초청…김건희 여사 올해는 불참

알리∙테무 초저가 상품의 숨겨진 비용…시민단체도 뿔났다

[단독] 이종섭 앞에서 막힌 ‘임성근 조사’…직권남용죄 가능성

‘그림자 전쟁’의 종말…중동이 요동친다

새 국회 순조롭게 열릴까…법사위원장 쟁탈 ‘먹구름’

홍준표, 의협 회장 ‘돼지 발정제’ 공격에 “논리 밀리니 인신공격”

국힘 원내대표 이종배·송석준·추경호 3파전…이철규 불출마

‘가황’은 나훈아뿐…사람들이 모르거나 오해하는 그의 이면

국힘 원내대표 불출마한 이철규 “당초부터 의사 없었다”

최불암 “휴머니즘 사라진 시대, ‘수사반장 박영한’이 필요한 이유는…”

hankyoreh

Links to other country sites 다른 나라 사이트 링크

[Photo] Samsung Bioepis launches biosimilar of world’s best-selling drug

Editorial・opinion

Most viewed articles